Associate Vice President of Pharmaceutical Intelligence
Institute for Clinical and Economic Review
Boston, MA
Maria joined the Institute for Clinical and Economic Review, also known as ICER, as the Director of Pharmaceutical Intelligence in May 2019 and was promoted to Associate Vice President of Pharmaceutical Intelligence in 2024. In this role, she is responsible for tracking developments in the drug pipeline and overseeing all horizon scanning activities to advise the ICER team on potential topics worthy of considering for future comparative and cost-effectiveness evaluation.
Maria received her PharmD from Northeastern University, completed a two-year fellowship in health outcomes research and pharmacoeconomics, and is a board-certified pharmacotherapy specialist. Since 2009 she has been invited to serve as an annual guest speaker about drugs in development at a variety of local and national meetings.
(K3) Specialty Pharmaceuticals in Development
Thursday, April 3, 2025
10:15 AM – 11:30 AM CST